Accompanied by the planning of the national 2030 health strategic plan, and the implementation of the national insulin special procurement in May 2022. In order to establish management norms for the safe use of insulin in medical institutions, standardize drug use and dressing change training, and promote and implement new technologies and new programs for the treatment of homogenized diabetes. In the context of VBP in 2022, the symposium on the scientific control of insulin in medical institutions and the safety of patient medication will be held offline+online on December 2, 2022. This conference will be hosted by Chengdu Hi tech Medical Association, which will bring together pharmaceutical and clinical experts to talk about the centralized collection of insulin and the management of hypoglycemic drugs. Tang Zhili, a professor from the Pharmaceutical Special Committee of Sichuan Hospital Association, and Jiang Tao, a professor from Mianyang Central Hospital Hospital, will be invited to the conference More than ten experts and scholars, including Professor Wu Xueyan of Guangyuan Central Hospital, Professor Xu Xunmei of Mianyang Third People's Hospital, and Professor Ye Wenchun of Mianyang Central Hospital, gave excellent lectures and held heated discussions on relevant topics. Representatives at the meeting expressed that they had benefited greatly and hoped to attend more similar meetings in the future.